
Tesla, IREN, and GE Vernova are the three Energy stocks to watch today, according to MarketBeat’s stock screener tool. Energy stocks are shares of companies involved in the production, exploration, refining, or distribution of energy, such as oil, natural gas, coal, and increasingly renewable energy. For stock market investors, they are a sector investment that tends to be influenced by commodity prices, global demand, geopolitics, and regulatory changes. These companies had the highest dollar trading volume of any Energy stocks within the last several days.
Tesla (TSLA)
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services.
IREN (IREN)
IREN Limited, formerly known as Iris Energy Limited, owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia.
Read Our Latest Research Report on IREN
GE Vernova (GEV)
GE Vernova LLC, an energy business company, generates electricity. It operates under three segments: Power, Wind, and Electrification. The Power segments generates and sells electricity through hydro, gas, nuclear, and steam power. Wind segment engages in the manufacturing and sale of wind turbine blades; and Electrification segment provides grid solutions, power conversion, solar, and storage solutions.
Read Our Latest Research Report on GEV
Read More
- MarketBeat’s Top Five Stocks to Own in May 2026
- IREN Is Flipping the Switch from Bitcoin to AI
- This Quantum Computing Stock May Be Closer to a Breakout Than You Think
- RTX Is Set to Revolutionize Munitions Manufacturing
- Microsoft Is Spending Billions on AI, But Investors Aren’t Buying It
- Is Co-Diagnostics National Security’s Next Diagnostic Pick?
